Trials / Completed
CompletedNCT02947035
Molecular Testing to Direct Extent of Initial Thyroid Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The research study consists of the participant agreeing to 1) the use of preoperative molecular testing (ThyroSeq) to guide extent of initial surgery and 2) the prospective collection of medical record data related to treatment of thyroid cancer.
Detailed description
The aim of the proposed pilot study is to use a clinical algorithm that incorporates molecular, clinical and radiographic factors to inform surgical management. This study is the first to propose molecular-directed surgical management for this commonly diagnosed cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Thyroid lobectomy | Thyroid lobectomy is removal of only part of the thyroid |
| PROCEDURE | Total thyroidectomy with CCND | Total thyroidectomy with central compartment lymph node dissection is removal of the entire thyroid with the surrounding lymph nodes |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2016-10-27
- Last updated
- 2023-07-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02947035. Inclusion in this directory is not an endorsement.